EUVIMEDEUVIMED entdecken
Crossref

Combinatory Immunotherapy for Glioblastoma Treatment

Muhammad Ijaz, Ikram Hasan, Zhiru Jiang, Zia Ullah, Bilal Aslam, Mohsin Khurshid, Yansun Sun, Bing Guo

Advanced Therapeutics · 2024-11 · 7 (11)

DOI: 10.1002/adtp.202400217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 02.10.2024. Verfasst von Muhammad Ijaz und 7 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 118 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in the treatment of glioblastoma, it faces challenges due to tumor heterogeneity, the blood‐brain barrier, recurrence, immune evasion, and conventional strategies, leading to low survival and a poor prognosis. Therefore, it is crucial to develop novel, useful treatment strategies for improving brain distribution to overcome blood‐brain barriers (BBB) and help the treatment of glioblastoma. Conventional immunotherapy like checkpoint inhibitors, CAR‐T cell therapy, monoclonal antibodies, cancer vaccines, and adoptive cell transfer often suffers from low therapeutic outcomes because the singular therapy generally has shortcomings, such as the cold immune microenvironment of brain tumors. In contrast, the emerging combinatory immunotherapy integrated with chemo‐immunotherapy, photothermal‐immunotherapy, and radio‐immunotherapy has shown great promise to modulate tumoral immune microenvironment and boost treatment outcomes. This review discusses the immune microenvironment of GBM, its impact on immunological effects, current immunotherapy methods, and advanced studies. It also introduces combinational GBM immunotherapy with traditional cancer therapies like chemo‐immunotherapy, surgery‐immunotherapy, photothermal‐immunotherapy, and radiotherapy‐immunotherapy. In the future, it is anticipated that this article will provide beneficial information and a path for the strategy of innovative, efficient combination immunotherapy in the treatment of glioblastoma.

Zitieren

APA

Ijaz, M., Hasan, I., Jiang, Z., Ullah, Z., Aslam, B., Khurshid, M., Sun, Y., & Guo, B. (2024). Combinatory Immunotherapy for Glioblastoma Treatment. Advanced Therapeutics, 7(11). https://doi.org/10.1002/adtp.202400217

Vancouver

Ijaz M, Hasan I, Jiang Z, Ullah Z, Aslam B, Khurshid M, et al. Combinatory Immunotherapy for Glioblastoma Treatment. Advanced Therapeutics. 2024;7(11). doi:10.1002/adtp.202400217

BibTeX
@article{Ijaz2024,
  author = {Ijaz, Muhammad and Hasan, Ikram and Jiang, Zhiru and Ullah, Zia and Aslam, Bilal and Khurshid, Mohsin and Sun, Yansun and Guo, Bing},
  title = {Combinatory Immunotherapy for Glioblastoma Treatment},
  journal = {Advanced Therapeutics},
  year = {2024},
  volume = {7},
  number = {11},
  doi = {10.1002/adtp.202400217}
}
Kostenlos starten →